Huashun Li

This inventor holds 11 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Asclepius (Suzhou) Technology Company Group Co., Ltd., Suzhou Thinking Power Biotechnology Co., Ltd., Other. Active years: 2019-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Huashun Li. Retrieved from https://idiyas.com/inventor/huashun-li

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 11 (Patent Applications = 4)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 2.4

ph-index = 1

Forward Citations = 5(Granted Patents)

Company Filing History:

9 out of 10

Asclepius (Suzhou) Technology Company Group Co., Ltd.

patents

1 out of 1

Suzhou Thinking Power Biotechnology Co., Ltd.

patent

1 out of 834,601

Other

patents

Years Active: 2019-2023

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11738051 - Nucleotide sequences for encoding CAR, ROBO1 CAR-NK cells of expressing the CAR, and preparation and application thereof (2023-08-29),

2. 11697685 - Chimeric antigen receptor cells targeting ROBO1, preparation method and use thereof (2023-07-11),

3. 11680106 - Bispecific antigen-binding construct and preparation method and use thereof (2023-06-20),

4. 11345893 - Anti-ROBO1 CAR-T cell, and preparation and application thereof (2022-05-31),

5. 11339225 - Bispecific antigen-binding construct and preparation method and use thereof (2022-05-24),

6. 11331345 - PD-1 CAR NK-92 cell and preparation method and use thereof (2022-05-17),

7. 11246888 - Slit2D2-chimeric antigen receptor and application thereof (2022-02-15),

8. 11149071 - Fusion protein Slit2D2(C386S)-HSA and use thereof in prevention and/or treatment of lung inflammation (2021-10-19),

9. 11041157 - Slit2D2-HSA fusion protein and use thereof against tumours (2021-06-22),

10. 10947296 - Fusion protein Slit2D2(C386S)-HSA and use thereof in treatment of fibrotic diseases (2021-03-16),

11. 10336813 - Fusion protein SLIT2D2-HSA and its use in treatment of sepsis (2019-07-02),

Title: Huashun Li: Pioneering Inventor from Suzhou

Introduction: Huashun Li is a renowned inventor hailing from Suzhou, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Huashun Li holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing his commitment to creating solutions for the future.

Career Highlights: With a career spanning over two decades, Huashun Li has worked with leading tech companies and research institutions, spearheading projects that have revolutionized industries worldwide.

Collaborations: Throughout his career, Huashun Li has collaborated with top scientists, engineers, and inventors, fostering a culture of innovation and knowledge-sharing that has led to numerous breakthroughs.

Conclusion: Huashun Li's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs, solidifying his legacy as a true pioneer in the world of technology.

Profile summary based on public USPTO records.